The Annals of Internal Medicine has rejected Health and Human Services Secretary Robert F. Kennedy Jr.'s call to retract a large Danish study on aluminum adjuvants in vaccines, with the journal's editor-in-chief stating she sees "no reason" to pull the paper, Reuters reported on August 11, 2025.

The Danish study analyzed data from 1.2 million people and concluded that aluminum ingredients used in vaccines do not increase health risks in children. Aluminum salts are among the most widely used adjuvants in pediatric immunization schedules globally — they enhance immune response and allow lower antigen doses. Kennedy had sought retraction of the paper, but the journal declined, with its editor-in-chief making her position unambiguous, according to HealthExec.

The episode is a direct collision between Kennedy's continued skepticism of vaccine safety data and the peer-reviewed literature he oversees as the nation's top health official. Retraction of published research is a defined, formal process: journals pull papers for fabrication, data manipulation, or material error — not because a public official disputes the conclusions. The Annals refusal follows that standard, and its editor's language left little procedural ambiguity.

The broader context here is Kennedy's dual position as a long-standing vaccine skeptic and the cabinet secretary responsible for agencies — the CDC, the FDA, the NIH — whose scientific credibility depends in part on their independence from political pressure on published research. His HHS reorganization plans, which aim to consolidate several currently siloed programs under a single administrative umbrella, have already drawn scrutiny over whether structural changes could insulate or, alternatively, expose scientific functions to executive influence. The retraction request sits in that same frame of reference for researchers and journal editors watching how the department evolves.

For the scientific publishing community, the Annals response is a clean application of editorial independence. Journals routinely receive pressure — from industry, governments, advocacy groups — to revisit inconvenient findings. What is unusual here is the source: a sitting U.S. cabinet secretary with jurisdiction over public health agencies that fund, conduct, and disseminate the very research such journals publish. The editor-in-chief's flat refusal signals that the journal is treating the request the same way it would any other unsupported retraction demand.

What Kennedy does next is the open question. He has no direct regulatory authority over scientific journals. His leverage, if any, runs through funding streams — NIH grants, CDC cooperative agreements, and HHS contracts that flow to academic institutions whose researchers publish in venues like the Annals. Whether that indirect pressure materializes, and whether Congress or other institutions push back if it does, will tell more about the durability of scientific independence under this administration than this single exchange resolves.